Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel vs Cisplatin with 5-FU in Esophageal Squamous Cell Carcinoma
NCT01591135Phase 3Completed
- Sponsor
- Fudan University
- Start
- Apr 2012
- Primary completion
- Aug 2018
- Modality
- Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of Paclitaxel Micelles for Injection in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by Fudan University. Started Apr 2012; status: completed.
02
Drugs
Paclitaxel Micelles for Injection
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT01591135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01591135.